Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study in Adults With Geographic Atrophy

ClinicalTrials.gov ID: NCT07606365

Public ClinicalTrials.gov record NCT07606365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 4:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicentre, Randomised, Double-masked, Placebo-controlled, Parallel-group, Dose-range Finding Study, to Assess the Efficacy and Safety of Oral STL303 in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical research study is to look at how safe STL303 is and whether it works when given to people with Geographic Atrophy (GA) secondary to Age-related Macular Degeneration (AMD). Geographic atrophy secondary to AMD is a condition where cells in the back part of the eye slowly die, causing a blurry, or missing spot in the centre of vision.

Study identification

NCT ID
NCT07606365
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sitala Bio LTD
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
60 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 11, 2026 (Actual)
Primary completion
Jul 2028 (Estimated)
Completion
Aug 2029 (Estimated)
Last update posted
Sep 21, 2026

2026 – 2029

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
California Retina Consultants Bakersfield California 93309 Not yet recruiting
Retina-Vitreous Associates Medical Group Beverly Hills California 90211 Not yet recruiting
Retina Specialists of Colorado Aurora Colorado 80012 Not yet recruiting
Retina Group of New England, PC Waterford Connecticut 06385 Not yet recruiting
University Retina and Macula Associates, P.C. Lemont Illinois 60439 Not yet recruiting
Cumberland Valley Retina Consultants,P.C. Hagerstown Maryland 21740 Not yet recruiting
Mid Atlantic Retina Specialists Hagerstown Maryland 21740 Not yet recruiting
Ophthalmic Consultants of Boston Waltham Massachusetts 02451 Not yet recruiting
Long Island and Queens Vitreoretinal Consultants of NY, P.C. Hauppauge New York 11788 Not yet recruiting
Erie Retina Research Erie Pennsylvania 16507 Recruiting
Tennessee Retina, PC Nashville Tennessee 37203 Not yet recruiting
Retina Consultants of Texas Bellaire Texas 77401 Not yet recruiting
Star Vision Research Burleson Texas 76028 Recruiting
Retina Consultants of Texas Schertz Texas 78154 Not yet recruiting
Northeast Wisconsin Retina Associates Appleton Wisconsin 54914 Not yet recruiting
Eye Clinic of Wisconsin Wausau Wisconsin 54403 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07606365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 21, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07606365 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →